These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. Yu HR; Schultz RM Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the frequency distribution for human hematogenous metastases: evidence for clustering and a power variance function. Kendal WS; Lagerwaard FJ; Agboola O Clin Exp Metastasis; 2000; 18(3):219-29. PubMed ID: 11315095 [TBL] [Abstract][Full Text] [Related]
6. Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene. Brunner G; Pohl J; Erkell LJ; Radler-Pohl A; Schirrmacher V J Cancer Res Clin Oncol; 1989; 115(2):139-44. PubMed ID: 2654132 [TBL] [Abstract][Full Text] [Related]
7. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700 [TBL] [Abstract][Full Text] [Related]